2019. Dextran Conjugation of Non–Steroidal Anti-Inflammatory Drug (Etodolac): A Colon Targeting Approach: Development of a Glucosamine-conjugated Etodolac Prodrug for Improved Targeting and Reduced Side Effects. Journal of Advances and Scholarly Researches in Allied Education. 16, 6 (May 2019), 3589–3595.